Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated calcium channels (VGCCs) are complex multi-subunit proteins that mediate the entry of calcium ions into cells upon membrane depolarization, acting as vital transducers of electrical signals into intracellular biological responses (Source: StatPearls, 'Physiology, Voltage-Gated Calcium Channels'). In various malignancies, VGCCs and other tumor-associated ion channels (such as certain potassium and sodium channels) are aberrantly expressed or regulated, a phenomenon often termed 'onco-channelopathy' (Source: Nature Reviews Cancer, 'Ion channels in cancer: from diagnosis to therapy'). These channels contribute to the hallmarks of cancer by promoting cell proliferation, inhibiting apoptosis, and facilitating epithelial-mesenchymal transition and metastasis through the modulation of calcium-dependent signaling cascades like MAPK/ERK and PI3K/Akt (Source: Frontiers in Pharmacology, 'Voltage-Gated Calcium Channels in Cancer'). While traditionally targeted for cardiovascular and neurological disorders, these channels are increasingly recognized as potential oncology targets due to their role in tumor pathophysiology (Source: PubMed, PMID: 28633251). However, the widespread physiological roles of these channels in the heart and brain necessitate the development of highly selective inhibitors or tumor-targeted delivery systems to minimize dose-limiting systemic toxicities (Source: Journal of Clinical Investigation, 'Ion channels as targets for cancer therapy').
Inhibition of calcium ion influx through the channel pore or modulation of channel gating properties to disrupt downstream signaling pathways involved in cell survival and proliferation (Source: PubMed, PMID: 30135518).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel (VGCC) and other tumor-associated ion channels (VGCC).